Pfizer Establishes Precision Medicine Research Collaboration With Medco

Loading...
Loading...
Pfizer Inc.
PFE
announced today that it has established a research collaboration with Medco Health Solutions, Inc.
MHS
and its wholly owned subsidiary, United BioSource Corporation (
UBC
), aimed at more effectively matching patients with treatments that will benefit them the most, thereby improving patient outcomes. The collaboration is intended to enhance Pfizer's precision medicine approach, which integrates genomic and phenotypic information, to help understand the underlying biology of disease and identify patients likely to benefit from a new drug. In the future, this approach could make it possible to precisely select disease targets and improve the safety and effectiveness of medical treatments in real-world practice.
Posted In: NewsContractsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...